ArticleBreast cancer (Dove Medical Press)2023

MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification.

Çağlar Ünal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.